BeOne Medicines (BEIGF) Free Cash Flow Growth (1y) (2016 - 2026)
BeOne Medicines (BEIGF) Free Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
1,092.51% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,092.51% |
| Dec 31, 2025 |
-29.99% |
| Sep 30, 2025 |
646.46% |
| Jun 30, 2025 |
229.26% |
| Mar 31, 2025 |
95.29% |
| Dec 31, 2024 |
159.92% |
| Sep 30, 2024 |
-10.74% |
| Jun 30, 2024 |
56.90% |
| Mar 31, 2024 |
46.16% |
| Dec 31, 2023 |
-53.78% |
| Sep 30, 2023 |
109.14% |
| Jun 30, 2023 |
-10.85% |
| Mar 31, 2023 |
-122.86% |
| Dec 31, 2022 |
-298.12% |
| Sep 30, 2022 |
-19.16% |
| Jun 30, 2022 |
8.51% |
| Mar 31, 2022 |
-399.07% |
| Dec 31, 2021 |
152.96% |
| Sep 30, 2021 |
-61.62% |
| Jun 30, 2021 |
-73.94% |
